Elliot Beimel

Harry O'Grady - Ipsen US LeadershipVice President, Finance, North America

Elliot Beimel brings more than 25 years of experience and a keen understanding of the pharmaceutical industry to his role as Vice President, Finance for Ipsen North America. In his role, he is responsible for the Accounting & Shared Services, Tax, Procurement, Government Pricing Reporting, Forecasting and Financial Planning & Analysis.

Elliot joined Ipsen in 2018 as Senior Director of Financial Planning & Analysis and assumed the additional responsibility of Forecasting in 2020. Prior to joining Ipsen, Elliot spent 18 years with Amgen Inc. based in California and the Netherlands. While at Amgen, Elliot held numerous roles of increasing responsibility across Technical Accounting & SEC Reporting, Corporate Finance, R&D Finance, Internal Audit, and Commercial Finance, most recently serving as Head of Finance for the US Oncology Business Unit. Prior to Amgen Elliot held roles with The Walt Disney Company and Arthur Andersen LLP.

Elliot holds a BS in Accounting from Indiana University, an MBA from the Anderson School of Management at UCLA and was a certified public accountant.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2022 Ipsen Biopharmaceuticals, Inc. MP-US-000472 June 2022